Mednax Ownership
| MD Stock | USD 14.24 0.52 3.79% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 85 M | Current Value 83 M | Avarage Shares Outstanding 91.4 M | Quarterly Volatility 6.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Mednax |
Mednax Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.54. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednax Inc has Price/Earnings To Growth (PEG) ratio of 0.88. The entity recorded a loss per share of 1.19. The firm had not issued any dividends in recent years. Mednax had 2:1 split on the 20th of December 2013. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people. To find out more about Mednax Inc contact James MD at 954 384 0175 or learn more at https://www.pediatrix.com.Besides selling stocks to institutional investors, Mednax also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Mednax's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Mednax's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Mednax Quarterly Liabilities And Stockholders Equity |
|
Mednax Insider Trades History
Only 1.62% of Mednax Inc are currently held by insiders. Unlike Mednax's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Mednax's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Mednax's insider trades
Mednax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mednax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mednax Inc backward and forwards among themselves. Mednax's institutional investor refers to the entity that pools money to purchase Mednax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | American Century Companies Inc | 2024-12-31 | 1.7 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.3 M | Charles Schwab Investment Management Inc | 2024-12-31 | 1.2 M | Caspian Capital Partners, L.p. | 2024-09-30 | 1.1 M | Northern Trust Corp | 2024-12-31 | 966.3 K | Jpmorgan Chase & Co | 2024-12-31 | 931.6 K | Renaissance Technologies Corp | 2024-12-31 | 838.8 K | Dana Investment Advisors Inc | 2024-12-31 | 826.8 K | Prudential Financial Inc | 2024-12-31 | 808.7 K | Blackrock Inc | 2024-12-31 | 14.2 M | Vanguard Group Inc | 2024-12-31 | 10.8 M |
Mednax Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mednax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mednax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mednax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mednax Outstanding Bonds
Mednax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mednax Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mednax bonds can be classified according to their maturity, which is the date when Mednax Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US58506YAS19 Corp BondUS58506YAS19 | View | |
| MEDTRONIC INC 4375 Corp BondUS585055BT26 | View | |
| MEDTRONIC INC 4625 Corp BondUS585055BU98 | View | |
| US58502BAE65 Corp BondUS58502BAE65 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Mednax Corporate Filings
F4 | 7th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 20th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of February 2025 Other Reports | ViewVerify | |
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 0.012 | Return On Assets |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.